Promising drug for Post-Transplant blood issues stalls after single patient
NCT ID NCT05502783
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study tested a drug called fostamatinib for people who develop low blood cell counts after a stem cell transplant. The goal was to see if the drug could help stabilize red blood cells or platelets without needing transfusions. The study was stopped early after enrolling only one person, so we don't have enough information to know if it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GVHD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.